[Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy]

Arch Soc Esp Oftalmol. 2014 Mar;89(3):130-2. doi: 10.1016/j.oftal.2012.11.008. Epub 2012 Dec 28.
[Article in Spanish]

Abstract

Case report: We report the case of a 28-year old woman suffering loss of visual acuity in her left eye, who presented an image suggestive of a subretinal neovascular membrane in her left eye, and bilateral retinal lesions compatible with punctate inner choroidopathy (PIC). She was treated with intravitreal ranibizumab obtaining excellent results.

Discussion: The differential diagnosis must be made between PIC and the rest of "white dot syndromes" and the presumed ocular histoplasmosis syndrome (POHS). Antiangiogenic drugs may be a good alternative for the treatment of such diseases when they develop a subretinal neovascular membrane.

Keywords: Angiogenesis inhibitors; Angiografía fluoresceínica; Antiangiogénicos; Coroidopatía punctata interna; Fluorescein angiography; Membrana neovascular; Neovascular membrane; Punctate inner choroidopathy; Ranibizumab.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Female
  • Humans
  • Intravitreal Injections
  • Ranibizumab
  • Uveitis, Posterior / drug therapy*
  • Uveitis, Posterior / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Ranibizumab